Skip to content
  • Log in
  • English
  • Deutsch
smv3.ch
Search
  • Home
  • About
    • About Mü
    • About Drug Discovery
  • Our business
    • Megatrends make our business
    • Mass Spectrometry in Discovery
    • Graphics & Web
  • News
  • Downloads/Uploads
  • Search

smv3 news

smv3 news

Preclinical drug development

28. December 20181. March 2018

Outsourced early development – Planning and managing a preclinical development with partner PKI

New webpage for mabritec

16. February 20192. February 2018

We congratulate MALDI bioapplications specialist mabritec AG to its upcoming 10th anniversary and its new website

Mass Spectrometry for Membrane Proteins

24. October 20181. February 2018

University of Oxford spinoff “OMass Technologies” visits Switzerland on march 16, 2018 – interested in meeting them?

Realization of art installation

24. October 201815. September 2017

Read about our work for Art exhibition “TonArt-TonWerk-DieZweite” in Lausen

smv3.ch enters Swiss Trade Register

30. October 201818. August 2017

smv3.ch enters Swiss Trade Register as GmbH

New analytical lecture for master students

30. January 20188. August 2017

The University of Basel hires smv3.ch for an analytical lecture in the ‘Master of Drug Sciences’ course

Sprache / Language

  • English
  • Deutsch

Data privacy

See our statement

Login Status

Contact and Impressum

Stephan Müller, Ph.D.
Schwieriweg 19
CH-4410 Liestal
Switzerland

+41 61 921 56 44 home office
+41 79 382 45 95 mobile

Send Mail

Google map
© smv3.ch; 2019
Click 'Details' to read about our restrictive data protection policy. If you continue to use the site we assume you agree to it. OKDetails